Despite significantly higher Css min plasma concentrations in CYP3A4*22 allele carriers (which theoretically could increase dose-dependent effects), no reliable association was found between this marker and systemic ADRs such as orthostatic hypotension or dizziness. This evidence concerns the gene CYP3A4 and hypotensive disorder.